OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling rare diseases with induced pluripotent stem cell technology
Ruthellen H. Anderson, Kevin R. Francis
Molecular and Cellular Probes (2018) Vol. 40, pp. 52-59
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Shruti Marwaha, Joshua W. Knowles, Euan A. Ashley
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 228

Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
Giuseppe Novelli, Paola Spitalieri, Michela Murdocca, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 24

Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine
Sounak Sahu, Shyam K. Sharan
iScience (2020) Vol. 23, Iss. 9, pp. 101485-101485
Open Access | Times Cited: 44

Integrating population genetics, stem cell biology and cellular genomics to study complex human diseases
Nona Farbehi, Drew Neavin, Anna Cuomo, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 758-766
Closed Access | Times Cited: 5

RNA Sequencing in Disease Diagnosis
Craig Smail, Stephen B. Montgomery
Annual Review of Genomics and Human Genetics (2024) Vol. 25, Iss. 1, pp. 353-367
Closed Access | Times Cited: 4

Precision Medicine in Rare Diseases
Irene Villalón-García, Mónica Álvarez-Córdoba, Juan M. Suárez-Rivero, et al.
Diseases (2020) Vol. 8, Iss. 4, pp. 42-42
Open Access | Times Cited: 25

Highly Efficient CRISPR‐Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells
Jean Ann Maguire, Fabian L. Cardenas‐Diaz, Paul Gadue, et al.
Current Protocols in Stem Cell Biology (2018) Vol. 48, Iss. 1
Open Access | Times Cited: 27

The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
Fiona Moghaddas, Seth L. Masters
Clinical Science (2018) Vol. 132, Iss. 17, pp. 1901-1924
Open Access | Times Cited: 26

Highly Efficient CRISPR/Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells
Jean Ann Maguire, Paul Gadue, Deborah L. French
Current Protocols (2022) Vol. 2, Iss. 11
Open Access | Times Cited: 13

A disease-specific iPS cell resource for studying rare and intractable diseases
Megumu K. Saito, Mitsujiro Osawa, Nao Tsuchida, et al.
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 8

Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway
Kathrin Haake, Anna‐Lena Neehus, Theresa Buchegger, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 483-483
Open Access | Times Cited: 19

Induced pluripotent stem cells from domesticated ruminants and their potential for enhancing livestock production
Prasanna Weeratunga, Rebecca Mattingly Harman, Gerlinde R. Van de Walle
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 7

Rare disease genomics and precision medicine
Juhyeon Hong, D. Lee, A. Hwang, et al.
Genomics & Informatics (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development
Olive Jung, Min Jae Song, Marc Ferrer
SLAS DISCOVERY (2021) Vol. 26, Iss. 9, pp. 1164-1176
Open Access | Times Cited: 13

Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients
Elena Genova, Federica Cavion, Marianna Lucafò, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 108, Iss. 2, pp. 358-367
Closed Access | Times Cited: 13

How Machine Learning and Statistical Models Advance Molecular Diagnostics of Rare Disorders Via Analysis of RNA Sequencing Data
Lea D. Schlieben, Holger Prokisch, Vicente A. Yépez
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 12

CRISPR-Cas9 mediated knockout of NDUFS4 in human iPSCs: A model for mitochondrial complex I deficiency
Shivani Goolab, Karin Terburgh, Charl du Plessis, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 2, pp. 167569-167569
Closed Access | Times Cited: 1

Recent Advances of COVID-19 Modeling Based on Regenerative Medicine
Bagher Larijani, Najmeh Foroughi-Heravani, Mina Abedi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8

A patient advocating for transparent science in rare disease research
Richard Rui Yang
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3

Quantitative Craniofacial Analysis and Generation of Human Induced Pluripotent Stem Cells for Muenke Syndrome: A Case Report
Fahad Kidwai, Byron W. H. Mui, Konstantinia Almpani, et al.
Journal of Developmental Biology (2021) Vol. 9, Iss. 4, pp. 39-39
Open Access | Times Cited: 7

Experimental therapies for osteopetrosis
Antonio Maurizi
Bone (2022) Vol. 165, pp. 116567-116567
Closed Access | Times Cited: 5

Increased p53 signaling impairs neural differentiation in HUWE1-promoted intellectual disabilities
Rossana Aprigliano, Merdane Ezgi Aksu, Stefano Bradamante, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100240-100240
Open Access | Times Cited: 6

VEGF Secretion Drives Bone Formation in Classical MAP2K1+ Melorheostosis
Jules D. Allbritton‐King, Jyotirindra Maity, Amit N. Patel, et al.
Journal of Bone and Mineral Research (2023) Vol. 38, Iss. 12, pp. 1834-1845
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top